Diversification of Business led by Integrated and R&D first approach
Maintain a Strong Product portfolio utilizing our research first approach
Market expansion leveraging our One-quality-for-all-markets assurance
Build large capacities and Invest early in businesses with high growth potential
Maintain high focus on our robust compliance and quality culture
Letting environmental stewardship essentially drive the business strategy (ESG focus)
New CDMO opportunities in allied domains through leveraging by cross–segment synergies
Invest early and nurture disruptive new technologies like Cell and Gene therapies
Continuously add to our access to advanced sustainable platforms & technologies
Deliver on Accelerated CAPEX Investments to support long-term growth and success